TIDMCIR

RNS Number : 5542Z

Circassia Pharmaceuticals Plc

29 December 2017

For immediate release

Circassia Pharmaceuticals plc

Total Voting Rights Update

29(th) December 2017

In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) confirms that the Company's issued share capital consists of 333,466,262 ordinary shares of 0.08p each in issue, each with equal voting rights. No shares are held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure and Transparency Rules.

-Ends-

 
 For further information, please contact: 
 
   Circassia Pharmaceuticals plc        +44 (0) 1865 
   Julien Cotta, Company Secretary      405560

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVREASASFLFXFFF

(END) Dow Jones Newswires

December 29, 2017 02:00 ET (07:00 GMT)

Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Circassia Charts.
Circassia (LSE:CIR)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Circassia Charts.